Mei Ri Jing Ji Xin Wen·2025-09-22 08:51Core Viewpoint - China Medical Investment Co., Ltd., a major shareholder of Jiukang Bio (SZ 300406), plans to increase its stake in the company by investing at least 30 million RMB from June 23, 2025, to December 22, 2025, through various trading methods [1] Group 1: Shareholder Actions - The major shareholder has already increased its stake by approximately 2.62 million shares, representing 0.45% of the company's voting shares, with an investment amount of about 35.7 million RMB [1] - The increase in shareholding is part of a broader strategy to enhance the company's market position and investor confidence [1] Group 2: Company Financials - Jiukang Bio's revenue for the year 2024 is expected to be entirely derived from the healthcare sector, with a 100% contribution from this segment [1] - As of the announcement date, Jiukang Bio's market capitalization stands at 7.8 billion RMB [1]